migraine market insight

DelveInsight’s ‘Migraine–Market Insights, Competitive Landscape, and Market Forecast—2030’ report deliver an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Migraine market report provides current treatment methods, emerging medical devices, market share based on treatment type, device placement and end-user, current and forecasted Migraine symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Migraine symptoms, medical devices used in treatment, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2018–2030

Migraine   Disease Understanding and Treatment

Migraine Overview

Migraine is a neurological condition that can cause multiple symptoms. It is frequently characterized by intense, debilitating headaches. A migraine is a moderate or severe headache felt as a throbbing pain on one side of the head. Symptoms may include nausea, vomiting, difficulty speaking, numbness or tingling, and sensitivity to light and sound. Migraines often run in families and affect all ages.

The exact cause of migraine is unknown, but they are thought to be the result of abnormal brain activity temporarily affecting nerve signals, chemicals and blood vessels in the brain. It is not clear what causes this change in brain activity, but the genes might make a person more likely to experience migraines as a result of a specific trigger.

The primary goals of migraine treatment have traditionally included relieving pain, restoring function, and reducing headache frequency. Treatment decisions are based on the type of migraine (episodic or chronic), the level of impairment they cause, previous treatment history, and patient preferences. In addition, clinicians must consider comorbid conditions and the potential for drug interactions with existing medications during treatment selection.

Apart from the pharmacological methods of treatment, non-pharmacological treatment options comprise of neurostimulation devices that are used for stimulation of a targeted area in the brain, thereby relieving or preventing the occurrence of migraine. Various neuromodulation treatments available for treatment of migraine comprise of supraorbital stimulation, vagus nerve stimulation, occipital nerve stimulation, transcranial magnetic stimulation, transcranial direct current stimulation, kinetic oscillation stimulation, remote electrical neuromodulation, among others.

Migraine Treatment

It covers the details of conventional and current medical devices available in the Migraine market for the treatment of migraine. It also provides country-wise treatment guidelines and algorithms across the United States, Europe, and Japan.

The DelveInsight Migraine market report gives a thorough understanding of the Migraine condition by including disease diagnosis, symptoms, causes, diagnosis and treatment. It also provides Migraine treatment algorithms and treatment guidelines in the US, Europe, and Japan.

Migraine Epidemiology

The epidemiology division’s Migraine   symptoms provide insights about the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Migraine epidemiology segmented as the Prevalence of Migraine, Prevalent Cases of Migraine based on Severity, Gender-specific Prevalence of migraine, and Diagnosed Cases of Episodic and Chronic Migraine. The report includes the incident Migraine scenario in 7MM, covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Migraine Epidemiology

The epidemiology segment also provides the Migraine   epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total 7MM prevalent cases of Migraine were 11,95,11,000 in 2020.

Migraine: List of Companies

• Cefaly Technology
• Neurolief Ltd.
• ElectroCore, INC
• tVNS technologies GmbH
• Theranica Bio-Electronic Ltd.
• eNeura, Inc.
• WAT Medical
• Chordate Medical
• Soterix Medical

Products detail in the report…

Migraine Product Profiles

Cefaly: Cefaly Technology

Cefaly is an at-home migraine solution. An External Trigeminal Nerve Stimulation device (e-TNS), CEFALY, sends tiny electrical impulses through a self-adhesive electrode placed on the forehead to stimulate the trigeminal nerve, reducing the frequency and intensity of migraine attacks. At the start of treatment, it may feel nothing or a slight tingling sensation, almost like hair standing on end. The sensation or tingling feeling increases gradually and spreads through the forehead and the head’s front part. After about 14 min, the intensity stabilizes and remains constant until the treatment session is over.

Products detail in the report…

Migraine Market Outlook

The Migraine market outlook of the report helps build a detailed comprehension of the historic, current, and forecasted Migraine market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

This segment gives a thorough detail of Migraine market trend of marketed medical device by evaluating their impact based on the cost of devices, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other medical device competitors, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Migraine market in 7MM is expected to change in the study period 2018–2030.

Key Findings

This section includes a glimpse of the Migraine market in 7MM. The market size of Migraine in the seven major markets was found to be USD 26.6 million in 2020.

The United States Market Outlook

This section provides a total of Migraine market size and market size by treatment type, by device placement and, by end-user in the United States.

The United States accounts for the highest Migraine market size compared to the EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.

EU-5 Countries: Market Outlook

The total Migraine market size in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Japan Market Outlook

The total Migraine market size in Japan are also mentioned.

Migraine Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the Migraine Market.  The rising prevalence and shift from pharmacological treatment, established treatment guidelines that can evolve in order to include medical devices, technological advancements and efficacious generation of medical devices.

However, a higher cost of the treatment and lack of reimbursement, lack of diagnostic tests for identification of migraine disorders and side effects associated with the neuromodulation devices can restrain the growth of this market.

Migraine Industry Trends

There have been various developments and collaborations in the field of Migraine devices. In September 2018, WAT Medical’s innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance. This product, already approved by CE, HC, and now FDA, has been distributed in over 20 countries worldwide. It has now officially entered the US market as an effective treatment for migraine headaches. Also, In May 2021, Chordate Medical received CE mark approval for neuromodulation treatment of chronic migraine.

KOL Views

To keep up with current market trends, we take KOLs and SME’s opinion working on Migraine domain through primary research to fill the data gaps and validate our secondary research. Their opinions help understand and validate current and emerging therapy treatment patterns or Migraine market trends. This will support the clients in potential upcoming novel treatment by identifying the market’s overall scenario and the unmet needs.

Competitive Intelligence Analysis

We perform a Competitive and Market Intelligence analysis of the Migraine Market by using various Competitive Intelligence tools. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

• The report covers the descriptive overview of Migraine, explaining the reasons for replacement, procedure, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Migraine is provided, which will have an impact on the future market of Migraine.
• A detailed review of Migraine market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Migraine market.

Report Highlights

• The report covers descriptive overview of the Migraine, explaining its applications, working mechanism, etc.
• The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.
• The report is a comprehensive account of marketed devices present in the Migraine market.
• The report also reviews the detailed global historical and forecasted Migraine devices market including assessing the outreach in 7 MM.
• The report helps in developing business strategies by understanding trends shaping and driving the global Migraine market.

Migraine Report Key Strengths

• 6 Years Forecast
• 7MM Coverage
• Competitive Landscape
• Patient Pool
• Market Size

Migraine Report Assessment

• Marketed Product profiles
• Key Products and Key Players
• Market Drivers and Barriers
• Market Forecast
• KOL’S views

Key Questions

Market Insights:

• What was the Migraine market share (%) distribution in 2018 and how it will look like in 2030?
• What will be the Migraine total market Size as well as market Size by devices across the 7MM during the forecast period (2018–2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Migraine Market Size during the forecast period (2018–2030)?
• At what CAGR, the Migraine market is expected to grow in 7MM during the forecast period (2018–2030)?
• What will be the Migraine market outlook across the 7MM during the forecast period (2018–2030)?
• What will be the Migraine market growth till 2030 and what will be the resultant market Size in the year 2030?
• How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Epidemiology Insights:

• What are the disease risk, burden, and unmet needs of Migraine?
• What is the historical Migraine   patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Migraine in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM concerning the patient population about Migraine?
• Out of all 7MM countries, which country would have the highest prevalent Migraine   population during the forecast period (2021–2030)?
• At what CAGR is the population expected to grow by 7MM during the forecast period (2021–2030)?

Competitive Landscape

• What are the current devices available in the Migraine market?
• What is the Migraine available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
• How many key players are developing Migraine?
• What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Migraine?
• What are the key designations that have been granted for the current Migraine?
• What are the global historical and forecasted market of Migraine?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Migraine market
• To understand the future market competition in the Migraine  market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Migraine   in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Migraine market
• To understand the future market competition in the Migraine market